Metraipolis › archive › dc_5e48c7aebcbe

The impact of β-blockers on outcomes of immune checkpoint inhibitors therapy in advanced lung cancer: a multicenter real-world study — Europe PMC PMID:41194930

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41194930
DOI
10.3389/fimmu.2025.1693249
License (as archived)
solo-consultazione
Archived
2026-11-09T04:28:29.282Z
SHA-256 of the archived text
0a527ec1a82056474379e7e16b88a853df7766bbfb53710001166b86ce014a7a
Stable URL of this page
https://metraipolis.com/documento/dc_5e48c7aebcbe

How to cite

The impact of β-blockers on outcomes of immune checkpoint inhibitors therapy in advanced lung cancer: a multicenter real-world study — Europe PMC PMID:41194930 — Europe PMC (en), https://europepmc.org/article/MED/41194930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e48c7aebcbe (Metraipolis archive dc_5e48c7aebcbe, sha256 0a527ec1a82056474379e7e16b88a853df7766bbfb53710001166b86ce014a7a)
BibTeX
@misc{dc5e48c7aebcbe,
  title = {The impact of β-blockers on outcomes of immune checkpoint inhibitors therapy in advanced lung cancer: a multicenter real-world study — Europe PMC PMID:41194930},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41194930},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e48c7aebcbe; sha256 0a527ec1a82056474379e7e16b88a853df7766bbfb53710001166b86ce014a7a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41194930. Agents can read the archived copy with the MCP tool read_document.